Simoa® for Cytokine Profiling and Antibody Detection in COVID-19 Research
The ability to differentiate elevated cytokine and chemokine levels, such as IL-6, IL-1b, IL-10, IL-8, and TNFα, from healthy baseline with the highest level of precision is critical to SARS-Cov-2 research. The Simoa SP-X Imaging and Analysis System is accelerating research efforts with the cost-effective solution for monitoring these targets with sensitivity and precision!
Now available on our HD-X platform, we are proud to introduce the ultra-sensitive Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody assay. Our assay targets antibodies directed against the viral spike protein and provides a numerical result representing the concentration of antibodies from 0.21 to 250 mg/mL. Learn more about its application by downloading the recently published app note.
SP-X Imaging and Analysis System
The Quanterix SP-X Imaging and Analysis System is a complete benchtop system that offers true multiplex detection at both acute and baseline levels.get more information
Th1/Th2 customizable panel with up to 10 critical markers for cytokine profiling and COVID-19 induced cytokine storm
|Plasma & Serum||IFNy||IL-1β||IL-4||IL-5||IL-6||IL-8||IL-10||IL-12p70||IL-22||TNFα|
Chemokine panel for cytokine storm
|Above LLOQ %||IP-10||ITAC||MCP-1||MIP-3b|
Angiogenesis panel monitoring and predicting vascular disease associated with COVID-19
|Above LLOQ %||ANG-2||HB-EGF||VEGF-C||PlGF||FGFb||HGF||VEGF|
COVID-19 Research Assay Menu
Does your research focus on neuropathy associated with SARS-Cov-2 infection?
Check out the extensive neurology menu on HD-X and SR-X providing the same level of sensitivity and precision as SP-X for your cytokine research